Pages that link to "Q77948597"
Jump to navigation
Jump to search
The following pages link to Protein kinase cepsilon has the potential to advance the recurrence of human prostate cancer (Q77948597):
Displaying 46 items.
- Inhibition of 5-lipoxygenase triggers apoptosis in prostate cancer cells via down-regulation of protein kinase C-epsilon (Q24633521) (← links)
- Mitogen Activated Protein kinase signal transduction pathways in the prostate (Q24802614) (← links)
- The use of time-resolved fluorescence imaging in the study of protein kinase C localisation in cells (Q24804929) (← links)
- Study designs to investigate Nox1 acceleration of neoplastic progression in immortalized human epithelial cells by selection of differentiation resistant cells (Q26852739) (← links)
- Tumor Suppression by RNA from C/EBPβ 3′UTR through the Inhibition of Protein Kinase Cε Activity (Q28743306) (← links)
- Protein kinase C isoforms: Multi-functional regulators of cell life and death (Q28818259) (← links)
- Dominant-negative PKC-epsilon impairs apical actin remodeling in parallel with inhibition of carbachol-stimulated secretion in rabbit lacrimal acini (Q30477049) (← links)
- Transcriptional regulation of oncogenic protein kinase Cϵ (PKCϵ) by STAT1 and Sp1 proteins. (Q33888667) (← links)
- Functional analysis of secreted caveolin-1 in mouse models of prostate cancer progression. (Q33921157) (← links)
- Regulation of prostate cancer cell survival by protein kinase Cepsilon involves bad phosphorylation and modulation of the TNFalpha/JNK pathway (Q34074278) (← links)
- Genetic Ablation of PKC Epsilon Inhibits Prostate Cancer Development and Metastasis in Transgenic Mouse Model of Prostate Adenocarcinoma (Q34690727) (← links)
- Differential regulation of gene expression by protein kinase C isozymes as determined by genome-wide expression analysis (Q34719591) (← links)
- Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A. (Q34986770) (← links)
- The expression and role of protein kinase C (PKC) epsilon in clear cell renal cell carcinoma (Q35344603) (← links)
- Locally generated methylseleninic acid induces specific inactivation of protein kinase C isoenzymes: relevance to selenium-induced apoptosis in prostate cancer cells (Q35676885) (← links)
- Protein kinase Cepsilon makes the life and death decision (Q36002759) (← links)
- Activation of nuclear factor κB (NF-κB) in prostate cancer is mediated by protein kinase C epsilon (PKCepsilon) (Q36347905) (← links)
- Plumbagin inhibits prostate cancer development in TRAMP mice via targeting PKCε, Stat3 and neuroendocrine markers (Q36435787) (← links)
- Serum caveolin-1, a biomarker of drug response and therapeutic target in prostate cancer models (Q36608696) (← links)
- Constitutive activation of STAT3 in breast cancer cells: A review (Q36711689) (← links)
- Phorbol-12-myristate 13-acetate acting through protein kinase Cepsilon induces translocator protein (18-kDa) TSPO gene expression (Q37104952) (← links)
- Protein kinase C epsilon: an oncogene and emerging tumor biomarker (Q37109953) (← links)
- PKC ε Phosphorylates and Mediates the Cell Membrane Localization of RhoA. (Q37245128) (← links)
- Tissue-specific conditional PKCε knockout mice: a model to precisely reveal PKCε functional role in initiation, promotion and progression of cancer (Q37362840) (← links)
- Preclinical development of a bifunctional cancer cell homing, PKCepsilon inhibitory peptide for the treatment of head and neck cancer (Q37375154) (← links)
- The role of caveolin-1 in prostate cancer: clinical implications. (Q37542947) (← links)
- Protein kinase C and cancer: what we know and what we do not. (Q38171231) (← links)
- The Multifunctional Protein Kinase C-ε in Cancer Development and Progression (Q38204165) (← links)
- CREB regulates AChE-R-induced proliferation of human glioblastoma cells (Q38340977) (← links)
- Plumbagin, a medicinal plant-derived naphthoquinone, is a novel inhibitor of the growth and invasion of hormone-refractory prostate cancer (Q38359505) (← links)
- Protein Kinase C Epsilon Cooperates with PTEN Loss for Prostate Tumorigenesis through the CXCL13-CXCR5 Pathway. (Q38707987) (← links)
- PKCε Is an Essential Mediator of Prostate Cancer Bone Metastasis (Q38869707) (← links)
- Protein kinase C in cancer: The top five unanswered questions. (Q39098659) (← links)
- Plumbagin, a medicinal plant (Plumbago zeylanica)-derived 1,4-naphthoquinone, inhibits growth and metastasis of human prostate cancer PC-3M-luciferase cells in an orthotopic xenograft mouse model (Q39219294) (← links)
- Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells (Q39540046) (← links)
- Transgenic overexpression of PKCε in the mouse prostate induces preneoplastic lesions (Q39609105) (← links)
- Protein kinase Cvarepsilon mediates Stat3Ser727 phosphorylation, Stat3-regulated gene expression, and cell invasion in various human cancer cell lines through integration with MAPK cascade (RAF-1, MEK1/2, and ERK1/2). (Q39727807) (← links)
- Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCε, Stat3, and Epithelial-to-Mesenchymal Transition Markers (Q40185493) (← links)
- Protein kinase Cɛ inhibition restores megakaryocytic differentiation of hematopoietic progenitors from primary myelofibrosis patients (Q40727272) (← links)
- Protein kinase C: an attractive target for cancer therapy. (Q41971372) (← links)
- Androgen receptor-target genes in african american prostate cancer disparities (Q42261015) (← links)
- Protein kinase C epsilon and genetic networks in osteosarcoma metastasis (Q42265507) (← links)
- COX-2 mediates pro-tumorigenic effects of PKCε in prostate cancer. (Q54979020) (← links)
- Identification of a novel biomarker in tangeretin‑induced cell death in AGS human gastric cancer cells (Q57070574) (← links)
- Imbalance in Protein Thiol Redox Regulation and Cancer-Preventive Efficacy of Selenium (Q88797989) (← links)
- Inhibitor 9 Combined With Androgen Deprivation Therapy or Chemotherapy Delays the Malignant Behavior of Castration-Resistant Prostate Cancer Through K-Ras/PLCε/PKCε Signaling Pathway (Q90220998) (← links)